- RecruitingPHASE1
A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
This study looks at combining radiotherapy with new drugs to treat non-small cell lung cancer that hasn't spread widely. Researchers want to find the safest and most effective dose of these new drugs, which help radiotherapy work better by making it harder for cancer cells to repair themselves.
For: Non Small Cell Lung CancerUnited Kingdom - RecruitingPHASE1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
This study is testing a new drug, AZD1390, alongside standard radiation for brain cancer. It's the first time AZD1390 has been given to patients. The main goal is to check its safety and how the body handles it, especially when combined with different types of radiation.
For: Recurrent Glioblastoma Multiforme · Primary Glioblastoma Multiforme · Brain Neoplasms, MalignantUnited States · Japan · United Kingdom - RecruitingPHASE2, PHASE3
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
This study is testing different treatments for a type of brain cancer called glioblastoma. It's for people who have been recently diagnosed or whose cancer has come back. The aim is to find better ways to treat this cancer.
For: GlioblastomaUnited States · Australia · Canada - Not yet recruitingPHASE1
Human ADME Study of [14C]-AZD1390
This study is looking at a new medicine called AZD1390 for people with advanced cancer. It's a very early-stage trial (Phase 1) to understand how the body handles this medicine: how it's absorbed, moves around, is changed, and leaves the body.
For: Advanced Solid MalignanciesUnited Kingdom